Clincosm LogoSign in Get a demo

nasopharyngeal carcinoma

Showing 26 - 50 of 346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma, De-escaltion Therapy Trial in Guangzhou (Reduced-target resection, Full-target resection, Adjuvant

Recruiting
  • Nasopharyngeal Carcinoma
  • De-escaltion Therapy
  • Reduced-target resection
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 25, 2023

Nasopharyngeal Carcinoma, Maintenance Therapy Trial in Guangzhou (Capecitabine/Placebo combined with treprizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Maintenance Therapy
  • Capecitabine/Placebo combined with treprizumab
  • Guangzhou, Guangdong, China
    SunYat-senU
May 11, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (Cadonilimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 27, 2023

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Nasopharyngeal Carcinoma, Radiotherapy; Complications Trial (Intensity Modulated Radiation Therapy, Chemotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Radiotherapy; Complications
  • (no location specified)
Mar 20, 2023

Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Mar 6, 2023

Nasopharyngeal Carcinoma, Liver Metastases Trial in Shanghai (Hepatectomy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Liver Metastases
  • Hepatectomy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 4, 2023

Toxicity Due to Radiotherapy, Nasopharyngeal Carcinoma Trial in Kunming (Target range)

Recruiting
  • Toxicity Due to Radiotherapy
  • Nasopharyngeal Carcinoma
  • Target range
  • Kunming, Yunnan, China
    First Affiliated Hospital of Kunming Medical University
Feb 14, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Dalpiciclib Isetionate Tablets, Camrelizumab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2023

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Sintilimab in Combination With Chemoradiotherapy in High-risk

Recruiting
  • Nasopharyngeal Carcinoma
  • Sintilimab
  • Sintilimab (PD-1 Antibody)
  • Nanning, Guangxi, China
    Guangxi Medical University Cancer Hospital
Jan 29, 2023

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Dynamic Changes of Plasma and Urine Metabolites of

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV Infection
  • Proteomics technology and liquid biopsy
  • Guangzhou, Guangdong, China
    Southern medical university
Jan 4, 2023

Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Jan 7, 2023

Nasopharyngeal Carcinoma Trial in Xuzhou (CAR-T Cell Injection, Fludarabine, cyclophosphamide)

Recruiting
  • Nasopharyngeal Carcinoma
  • CAR-T Cell Injection
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 15, 2022

Nasopharyngeal Carcinoma Trial in Xuzhou (BGT007 Cell Injection, Fludarabine, cyclophosphamide)

Recruiting
  • Nasopharyngeal Carcinoma
  • BGT007 Cell Injection
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 14, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Cancer
  • Bengbu, Anhui, China
  • +12 more
Dec 13, 2022

Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

Recruiting
  • Advanced Solid Tumor
  • +11 more
  • Boston, Massachusetts
  • +30 more
Dec 1, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Nasopharyngeal Carcinoma Trial in China (TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride

Recruiting
  • Nasopharyngeal Carcinoma
  • TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Nov 28, 2022

Nasopharyngeal Carcinoma Trial in Beijing (Donafenib)

Recruiting
  • Nasopharyngeal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital of Medical College
Nov 28, 2022

Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)

Recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Nov 15, 2022